First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.
"synopsis" may belong to another edition of this title.
Shipping:
£ 4.50
From United Kingdom to U.S.A.
Book Description paperback. Condition: New. Language: ENG. Seller Inventory # 9780415815642
Book Description Condition: New. Seller Inventory # 21450848-n
Book Description Condition: New. Book is in NEW condition. Seller Inventory # 0415815649-2-1
Book Description Condition: New. New! This book is in the same immaculate condition as when it was published. Seller Inventory # 353-0415815649-new
Book Description Condition: New. Seller Inventory # ABLIING23Feb2215580204231
Book Description Paperback / softback. Condition: New. New copy - Usually dispatched within 4 working days. Seller Inventory # B9780415815642
Book Description Paperback. Condition: Brand New. reissue edition. 440 pages. 8.50x5.75x1.25 inches. In Stock. This item is printed on demand. Seller Inventory # __0415815649
Book Description PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9780415815642
Book Description Condition: New. Seller Inventory # 21450848-n
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9780415815642_lsuk